{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:18:00Z","timestamp":1792001880391,"version":"4.4.0"},"reference-count":209,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>HBV infection is a key risk factor for the development and progression of hepatocellular carcinoma (HCC), a highly invasive tumor, and is characterized by its persistent immunosuppressive microenvironment. This review provides an in-depth analysis of HBV-related HCC and explores the interactions between neutrophils, natural killer cells, and dendritic cells, examining their roles in regulating tumor-associated macrophages and CD8+ T cells and shaping the tumor microenvironment. Two critical players in the immunosuppressive milieu of HBV-related HCC are CD8+ T cells and tumor-associated macrophages (TAMs). The study explores how TAMs, initially recruited to combat infection, transform, adopting a tumor-promoting phenotype, turning against the body, promoting tumor cell proliferation, suppressing anti-tumor immunity, and assisting in the spread of cancer. Meanwhile, CD8+ T cells, crucial for controlling HBV infection, become dysfunctional and exhausted in response to persistent chronic viral inflammation. The review then dissects how TAMs manipulate this immune response, further depleting CD8+ T cell functions through mechanisms like arginine deprivation and creating hypoxic environments that lead to exhaustion. Finally, it explores the challenges and promising therapeutic avenues that target TAMs and CD8+ T cells, either separately or in combination with antiviral therapy and personalized medicine approaches, offering hope for improved outcomes in HBV-related HCC.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1472430","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T07:48:51Z","timestamp":1728546531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC"],"prefix":"10.3389","volume":"15","author":[{"given":"Muhammad Naveed","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binli","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur J Cancer"},{"key":"B3","unstructured":"World Health organizationHepatitis B2023"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12806","article-title":"Towards personalized medicine in chronic HBV patients","volume":"35","author":"Sitia","year":"2015","journal-title":"Liver Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/v13020210","article-title":"Hepatitis B virus DNA integration and clonal expansion of hepatocytes in the chronically infected liver","volume":"13","author":"Mason","year":"2021","journal-title":"Viruses"},{"key":"B6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41420-023-01356-7","article-title":"Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy","volume":"9","author":"Zheng","year":"2023","journal-title":"Cell Death Discovery"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1431211","article-title":"Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy","volume":"15","author":"Du","year":"2024","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0960","article-title":"Hepatocellular carcinoma immune microenvironment analysis: A comprehensive assessment with computational and classical pathology","author":"Ercan","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1034842","article-title":"TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress","volume":"12","author":"Shen","year":"2022","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.54457\/DR.202302001","article-title":"Review on tumour microenvironment cell types associated with metastatic cancer","volume":"3","author":"Choudhary","year":"2023","journal-title":"Dis Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.3390\/cancers15204977","article-title":"Targeting the heterogeneous tumour-associated macrophages in hepatocellular carcinoma","volume":"15","author":"Agirre-Lizaso","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12885-023-11804-3","article-title":"Identification of CD8(+) T-cell exhaustion signatures for prognosis in HBV-related hepatocellular carcinoma patients by integrated analysis of single-cell and bulk RNA-sequencing","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cancer"},{"key":"B15","article-title":"T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy","volume":"10","author":"Bian","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","article-title":"A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41421-020-00214-5","article-title":"Global immune characterization of HBV\/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression","volume":"6","author":"Song","year":"2020","journal-title":"Cell Discovery"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000393","article-title":"More immunosuppressive, more immunotherapy responsive? A double-edged sword of HBV-induced immune response in HCC","volume":"78","author":"Huang","year":"2023","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/imm.v171.4","article-title":"The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma","volume":"171","author":"He","year":"2024","journal-title":"Immunology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166052","article-title":"Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC","volume":"14","author":"Shi","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1033497","article-title":"The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1160340","article-title":"Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities","volume":"14","author":"Han","year":"2023","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2198209","article-title":"The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review","volume":"19","author":"Allahmoradi","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12943-024-02004-z","article-title":"Neutrophils in Cancer immunotherapy: friends or foes","volume":"23","author":"Huang","year":"2024","journal-title":"Mol Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/imr.v314.1","article-title":"N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology","volume":"314","author":"Antuamwine","year":"2023","journal-title":"Immunol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/vaccines11061028","article-title":"Neutrophils in cancer and potential therapeutic strategies using neutrophil-derived exosomes","volume":"11","author":"Dutta","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02100","article-title":"Plasticity in pro- and anti-tumor activity of neutrophils: shifting the balance","volume":"11","author":"Furumaya","year":"2020","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.3390\/cancers13122899","article-title":"Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy","volume":"13","author":"Arvanitakis","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001946","article-title":"Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3","volume":"9","author":"Zhou","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"113543","DOI":"10.1016\/j.biopha.2022.113543","article-title":"Tannins in Terminalia bellirica inhibits hepatocellular carcinoma growth via re-educating tumor-associated macrophages and restoring CD8(+)T cell function","volume":"154","author":"Chang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers14010226","article-title":"Tumor-associated macrophages in hepatocellular carcinoma pathogenesis, prognosis and therapy","volume":"14","author":"Arvanitakis","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2052418","DOI":"10.1080\/2162402X.2022.2052418","article-title":"Neutrophil extracellular traps induce tumor metastasis through dual effects on cancer and endothelial cells","volume":"11","author":"Jiang","year":"2022","journal-title":"Oncoimmunology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40364-023-00463-y","article-title":"Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target","volume":"11","author":"Shang","year":"2023","journal-title":"biomark Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-024-12074-3","article-title":"The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma","volume":"24","author":"Lee","year":"2024","journal-title":"BMC Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887186","article-title":"The dynamic role of NK cells in liver cancers: role in HCC and HBV associated HCC and its therapeutic implications","volume":"13","author":"Sajid","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1084109","article-title":"Prospects for NK-based immunotherapy of chronic HBV infection","volume":"13","author":"Jin","year":"2022","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643310","article-title":"Natural killer cells and regulatory T cells cross talk in hepatocellular carcinoma: exploring therapeutic options for the next decade","volume":"12","author":"Bozward","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.06.009","article-title":"Disruption of TGF-beta signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells","author":"Thangaraj","year":"2024","journal-title":"Cell Stem Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"216568","DOI":"10.1016\/j.canlet.2023.216568","article-title":"Blocking MARCO(+) tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway","volume":"582","author":"Ding","year":"2024","journal-title":"Cancer Lett"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-024-01907-3","article-title":"Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization","volume":"73","author":"Sezginer","year":"2024","journal-title":"Inflammation Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2095","article-title":"The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment","volume":"26","author":"Borst","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s40425-019-0761-3","article-title":"Monalizumab: inhibiting the novel immune checkpoint NKG2A","volume":"7","author":"van Hall","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13877","article-title":"The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus-related hepatocellular carcinoma","volume":"53","author":"Yu","year":"2023","journal-title":"Hepatol Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"111548","DOI":"10.1016\/j.intimp.2024.111548","article-title":"The role of dendritic cells in cancer immunity and therapeutic strategies","volume":"128","author":"Tai","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b07716","article-title":"Different-sized gold nanoparticle activator\/antigen increases dendritic cells accumulation in liver-draining lymph nodes and CD8+ T cell responses","volume":"10","author":"Zhou","year":"2016","journal-title":"ACS Nano"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7378","DOI":"10.3390\/ijms21197378","article-title":"Dendritic cell and T cell crosstalk in liver fibrogenesis and hepatocarcinogenesis: implications for prevention and therapy of liver cancer","volume":"21","author":"Lurje","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12943-024-02104-w","article-title":"Phenotypic and spatial heterogeneity of CD8(+) tumour infiltrating lymphocytes","volume":"23","author":"Sun","year":"2024","journal-title":"Mol Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-022-02458-3","article-title":"Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma Malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway","volume":"41","author":"Xu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e530","DOI":"10.1002\/agt2.v5.3","article-title":"Tracking interactions between TAMs and CAFs mediated by arginase-induced proline production during immune evasion of HCC","volume":"5","author":"Wu","year":"2024","journal-title":"Aggregate"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4654","article-title":"Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma","volume":"13","author":"Wang","year":"2016","journal-title":"Mol Med Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2015.10.007","article-title":"A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice","volume":"168","author":"Yu","year":"2015","journal-title":"Immunol Lett"},{"key":"B52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/art.42484","article-title":"Non-redundant roles of T cell costimulation pathways in inflammatory arthritis revealed by dual blockade of ICOS and CD28 with acazicolcept (ALPN-101)","volume":"75","author":"Dillon","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1615\/CritRevImmunol.2018026790","article-title":"Immunomodulatory bonds of the partnership between dendritic cells and T cells","volume":"38","author":"Bourque","year":"2018","journal-title":"Crit Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666181106114421","article-title":"Manipulation of the immune system for cancer defeat: A focus on the T cell inhibitory checkpoint molecules","volume":"27","author":"D\u2019Arrigo","year":"2020","journal-title":"Curr Med Chem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1708876","article-title":"Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis","volume":"40","author":"Matsuda","year":"2020","journal-title":"Semin Liver Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.v42.11","article-title":"Tumor-associated macrophages in liver cancer: From mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01799","article-title":"Ontogeny of tumor-associated macrophages","volume":"10","author":"Laviron","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbcan.2015.06.009","article-title":"Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment","volume":"1865","author":"Lahmar","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B61","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","article-title":"Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma","volume":"183","author":"Sharma","year":"2020","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-3106","article-title":"Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy","volume":"84","author":"Weng","year":"2024","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.722916","article-title":"CCL2: an important mediator between tumor cells and host cells in tumor microenvironment","volume":"11","author":"Jin","year":"2021","journal-title":"Front Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10321","DOI":"10.1038\/ncomms10321","article-title":"Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells","volume":"7","author":"Scott","year":"2016","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307671","article-title":"Tim-3 fosters HCC development by enhancing TGF-beta-mediated alternative activation of macrophages","volume":"64","author":"Yan","year":"2015","journal-title":"Gut"},{"key":"B66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.coi.2018.03.009","article-title":"Plasticity of myeloid-derived suppressor cells in cancer","volume":"51","author":"Tcyganov","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/antiox11071394","article-title":"Macrophage polarization and reprogramming in acute inflammation: A redox perspective","volume":"11","author":"Perez","year":"2022","journal-title":"Antioxid (Basel)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"107823","DOI":"10.1016\/j.intimp.2021.107823","article-title":"Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes","volume":"97","author":"Arabpour","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0866","article-title":"Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma","volume":"16","author":"Ao","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00897-y","article-title":"Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma","volume":"23","author":"Xu","year":"2023","journal-title":"Clin Exp Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"13317","DOI":"10.3390\/ijms241713317","article-title":"Vascular endothelial growth factor-D (VEGF-D): an angiogenesis bypass in Malignant tumors","volume":"24","author":"Bokhari","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4174\/astr.2015.89.1.1","article-title":"Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis","volume":"89","author":"Lee","year":"2015","journal-title":"Ann Surg Treat Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04949-y","article-title":"Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model","volume":"149","author":"Kong","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","article-title":"Crosstalk between hepatic tumor cells and macrophages via Wnt\/beta-catenin signaling promotes M2-like macrophage polarization and reinforces tumor Malignant behaviors","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2020.03.012","article-title":"Interleukin-37 suppresses hepatocellular carcinoma growth through inhibiting M2 polarization of tumor-associated macrophages","volume":"122","author":"Zhang","year":"2020","journal-title":"Mol Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3587","article-title":"Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression","volume":"33","author":"Kang","year":"2015","journal-title":"Oncol Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-023-04741-8","article-title":"lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages","volume":"80","author":"Ye","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/or.2021.7988","article-title":"Downregulation of triggering receptor expressed on myeloid cells 1 inhibits invasion and migration of liver cancer cells by mediating macrophage polarization","volume":"45","author":"Chen","year":"2021","journal-title":"Oncol Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.725595","article-title":"The transcription of ZIP9 is associated with the macrophage polarization and the pathogenesis of hepatocellular carcinoma","volume":"13","author":"Gou","year":"2022","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17973","article-title":"M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"B82","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12885-023-11027-6","article-title":"Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/tjg.2022.19813","article-title":"The biomarkers for predicting viral hepatitis associated hepatocellular carcinoma","volume":"33","author":"Yang","year":"2022","journal-title":"Turk J Gastroenterol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"11051","DOI":"10.3390\/ijms222011051","article-title":"Blood-based biomarkers in hepatitis B virus-related hepatocellular carcinoma, including the viral genome and glycosylated proteins","volume":"22","author":"Hayashi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yexcr.2019.03.005","article-title":"TNF-alpha derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt\/beta-catenin pathway in SMMC-7721 hepatocellular carcinoma cells","volume":"378","author":"Chen","year":"2019","journal-title":"Exp Cell Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.764727","article-title":"Transforming growth factor-beta: an agent of change in the tumor microenvironment","volume":"9","author":"Stuelten","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-021-00252-z","article-title":"Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies","volume":"10","author":"Zhu","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41374-022-00731-9","article-title":"LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma","volume":"102","author":"Tao","year":"2022","journal-title":"Lab Invest"},{"key":"B89","doi-asserted-by":"publisher","first-page":"8785567","DOI":"10.1155\/2022\/8785567","article-title":"HBV infection-related PDZK1 plays an oncogenic role by regulating the PI3K-Akt pathway and fatty acid metabolism and enhances immunosuppression","volume":"2022","author":"Chen","year":"2022","journal-title":"J Immunol Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1601479","DOI":"10.1080\/2162402X.2019.1601479","article-title":"SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC","volume":"8","author":"Yin","year":"2019","journal-title":"Oncoimmunology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol Cell"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.11.007","article-title":"Metabolic interplay: tumor macrophages and regulatory T cells","volume":"10","author":"Vilbois","year":"2024","journal-title":"Trends Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.04.057","article-title":"Natural killer cells involved in tumour immune escape of hepatocellular carcinomar","volume":"73","author":"Han","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12967-024-05033-w","article-title":"Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy","volume":"22","author":"Miao","year":"2024","journal-title":"J Transl Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/cancers11101568","article-title":"Platelets and hepatocellular cancer: bridging the bench to the clinics","volume":"11","author":"Lai","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1382256","article-title":"Tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00527","article-title":"Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy","volume":"9","author":"Albini","year":"2018","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.4110\/in.2021.21.e37","article-title":"Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation","volume":"21","author":"Son","year":"2021","journal-title":"Immune Netw"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1363996","article-title":"Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review","volume":"15","author":"Soleiman-Meigooni","year":"2024","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2018.08.025","article-title":"Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-alpha and MMP-9","volume":"437","author":"Lee","year":"2018","journal-title":"Cancer Lett"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6657","article-title":"Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR\/ERK1\/2 pathway in head and neck squamous cell carcinoma","volume":"40","author":"Gao","year":"2018","journal-title":"Oncol Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S168317","article-title":"Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition","volume":"11","author":"Chen","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1186\/s12935-021-02326-8","article-title":"Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.7150\/thno.71873","article-title":"Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"B106","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/or.2022.8282","article-title":"Inhibition of the VEGF signaling pathway attenuates tumor\u2212associated macrophage activity in liver cancer","volume":"47","author":"Okikawa","year":"2022","journal-title":"Oncol Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"116154","DOI":"10.1016\/j.bcp.2024.116154","article-title":"Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights","volume":"223","author":"Yuan","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12935-018-0590-3","article-title":"MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma","volume":"18","author":"Li","year":"2018","journal-title":"Cancer Cell Int"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.v119.3","article-title":"Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1\/M2 macrophage polarization","volume":"119","author":"Ye","year":"2018","journal-title":"J Cell Biochem"},{"key":"B110","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.213108","article-title":"Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer","volume":"286","author":"Liu","year":"2011","journal-title":"J Biol Chem"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-37","article-title":"Effect of IL-8 on hepatocellular carcinoma-associated metastasis by targeting MMP9 in mice","volume":"11","author":"Xue","year":"2022","journal-title":"Transl Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-019-02217-5","article-title":"MiR-130b\/TNF-alpha\/NF-kappaB\/VEGFA loop inhibits prostate cancer angiogenesis","volume":"22","author":"Mu","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"155436","DOI":"10.1016\/j.cyto.2021.155436","article-title":"MiR-325-3p mediate the CXCL17\/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma","volume":"141","author":"Li","year":"2021","journal-title":"Cytokine"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1191070","article-title":"Little things with significant impact: miRNAs in hepatocellular carcinoma","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/cells11040741","article-title":"Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: A comprehensive review","volume":"11","author":"Sivasudhan","year":"2022","journal-title":"Cells"},{"key":"B117","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12929-019-0534-9","article-title":"Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis","volume":"26","author":"Yen","year":"2019","journal-title":"J BioMed Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e111618","DOI":"10.5812\/hepatmon.111618","article-title":"Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter","volume":"21","author":"Luan","year":"2021","journal-title":"Hepat Mon"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005531","article-title":"CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis","volume":"5","author":"Gerosa","year":"2021","journal-title":"Blood Adv"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/or.2019.7397","article-title":"Hypoxia\u2212inducible factors in hepatocellular carcinoma (Review)","volume":"43","author":"Guo","year":"2020","journal-title":"Oncol Rep"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1086813","article-title":"Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Pharmacol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S411492","article-title":"Antigen recognition and immune response to acute and chronic hepatitis B virus infection","volume":"16","author":"Adugna","year":"2023","journal-title":"J Inflammation Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/blood-2023-188897","article-title":"Virus-specific CD8+ Stem memory T lymphocytes display enhanced anti-virus responses","volume":"142","author":"Cao","year":"2023","journal-title":"Blood"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028464","article-title":"Cytokine-mediated regulation of CD8 T-cell responses during acute and chronic viral infection","volume":"11","author":"Hashimoto","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1045498","article-title":"Immune escape pathways from the HBV core(18-27) CD8 T cell response are driven by individual HLA class I alleles","volume":"13","author":"Walker","year":"2022","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.v29.10","article-title":"Hepatitis B e antigen and e antibody in a multi-ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years","volume":"29","author":"Mutimer","year":"2022","journal-title":"J Viral Hepat"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00769-7","article-title":"HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance","volume":"18","author":"Xie","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.797915","article-title":"HBeAg is indispensable for inducing liver sinusoidal endothelial cell activation by hepatitis B virus","volume":"12","author":"Xie","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700921","article-title":"Local stimulation of liver sinusoidal endothelial cells with a NOD1 agonist activates T cells and suppresses hepatitis B virus replication in mice","volume":"200","author":"Huang","year":"2018","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301262","article-title":"TLR1\/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro","volume":"191","author":"Liu","year":"2013","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02981","article-title":"High levels of eomes promote exhaustion of anti-tumor CD8(+) T cells","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13470","article-title":"HBV-specific CD8 T cells present higher TNF-alpha expression but lower cytotoxicity in hepatocellular carcinoma","volume":"201","author":"Zhao","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13046-016-0416-x","article-title":"Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy","volume":"35","author":"Takeda","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1107483","article-title":"Decreased granzyme-B expression in CD11c(+)CD8(+) T cells associated with disease progression in patients with HBV-related hepatocellular carcinoma","volume":"14","author":"Gao","year":"2023","journal-title":"Front Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e38713","DOI":"10.1097\/MD.0000000000038713","article-title":"Construction and validation of prognostic signature for transcription factors regulating T cell exhaustion in hepatocellular carcinoma","volume":"103","author":"Jin","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1375864","article-title":"Prognostic value of CD8(+)T cells related genes and exhaustion regulation of Notch signaling pathway in hepatocellular carcinoma","volume":"15","author":"Pu","year":"2024","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.210.Supp.154.15","article-title":"Discovery of a molecular clock that controls CD8+ T cell function and exhaustion","volume":"210","author":"Mann","year":"2023","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"A1232","DOI":"10.1136\/jitc-2023-SITC2023.1119","article-title":"1119 Selective reversal of key features of T cell exhaustion in an in vitro model by a SMARCA4\/2 ATPase inhibitor","volume":"11","author":"Kleiman","year":"2023","journal-title":"J ImmunoTher Cancer"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200681","article-title":"Regulation and immunotherapeutic targeting of the epigenome in exhausted CD8 T cell responses","volume":"210","author":"Ford","year":"2023","journal-title":"J Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.09.031","article-title":"CXCL13-mediated recruitment of intrahepatic CXCR5(+)CD8(+) T cells favors viral control in chronic HBV infection","volume":"72","author":"Li","year":"2020","journal-title":"J Hepatol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12865-019-0309-9","article-title":"CD4(+) T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B","volume":"20","author":"Dong","year":"2019","journal-title":"BMC Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v15.i12.2138","article-title":"Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responses","volume":"15","author":"Zhang","year":"2023","journal-title":"World J Gastrointest Oncol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31466","article-title":"Transcriptome profiling identifies TIGIT as a marker of T-cell exhaustion in liver cancer","volume":"73","author":"Ostroumov","year":"2021","journal-title":"Hepatology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/ijms18071517","article-title":"Programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) in viral hepatitis","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.01.026","article-title":"TIM-3 as a marker of exhaustion in CD8(+) T cells of active chronic hepatitis B patients","volume":"128","author":"Mohammadizad","year":"2019","journal-title":"Microb Pathog"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-015-5314-y","article-title":"Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection","volume":"53","author":"Dinney","year":"2015","journal-title":"J Microbiol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12967-024-05069-y","article-title":"HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma","volume":"22","author":"Jia","year":"2024","journal-title":"J Transl Med"},{"key":"B148","article-title":"Evaluation of peripheral blood T-lymphocyte subpopulations features in patients with hepatitis B virus-related acute-on-chronic liver failure based on single-cell sequencing technology","volume":"31","author":"Peng","year":"2023","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B149","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/jmedgenet-2018-105267","article-title":"Genetic and phenotypic difference in CD8(+) T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma","volume":"56","author":"Wang","year":"2019","journal-title":"J Med Genet"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.884290","article-title":"Natural killer cells induce CD8(+) T cell dysfunction via galectin-9\/TIM-3 in chronic hepatitis B virus infection","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1200\/JCO.2024.42.3_suppl.543","article-title":"The combination of CD8 and TIM3 expression to predict survival outcomes in hepatocellular carcinoma","volume":"42","author":"Shimada","year":"2024","journal-title":"J Clin Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13958","article-title":"Current research insights into the role of CTLA-4 in hepatitis B virus (HBV) infection","volume":"31","author":"Gu","year":"2024","journal-title":"J Viral Hepat"},{"key":"B153","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12865-022-00537-w","article-title":"CTLA4(+)CD4(+)CXCR5(-)FOXP3(+) T cells associate with unfavorable outcome in patients with chronic HBV infection","volume":"24","author":"Wen","year":"2023","journal-title":"BMC Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31466","article-title":"Transcriptional profiling of tumor-specific CD8 T-cells shows contribution of TIGIT to T-cell exhaustion in liver cancer","volume":"73","author":"Ostroumov","year":"2021","journal-title":"Hepatology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02426-5","article-title":"PD-1(+) TIGIT(+) CD8(+) T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma","volume":"68","author":"Liu","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B156","article-title":"Cyclooxygenase-2 expressed hepatocellular carcinoma induces cytotoxic T lymphocytes exhaustion through M2 macrophage polarization","volume":"13","author":"Xun","year":"2021","journal-title":"Am J Transl Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/jpm13121675","article-title":"The role of interleukins in HBV infection: A narrative review","volume":"13","author":"Dimitriadis","year":"2023","journal-title":"J Pers Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2013.38","article-title":"Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells","volume":"91","author":"Harimoto","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2018028252","article-title":"Roles of lamtor1 in macrophages, CD4+ T-cells, and regulatory T-cells","volume":"38","author":"Kimura","year":"2018","journal-title":"Crit Rev Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J Hepatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96061","article-title":"PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression","volume":"128","author":"Tang","year":"2018","journal-title":"J Clin Invest"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02133-5","article-title":"Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma","volume":"41","author":"Xia","year":"2022","journal-title":"Oncogene"},{"key":"B163","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s11658-023-00438-9","article-title":"Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance","volume":"28","author":"Hashemi","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646949","article-title":"Hepatic dendritic cells, the tolerogenic liver environment, and liver disease","volume":"38","author":"Dou","year":"2018","journal-title":"Semin Liver Dis"},{"key":"B165","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4049\/jimmunol.2000300","article-title":"SLAMF7 signaling reprograms T cells toward exhaustion in the tumor microenvironment","volume":"206","author":"O\u2019Connell","year":"2021","journal-title":"J Immunol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.2017.276.issue-1","article-title":"Potential targeting of B7-H4 for the treatment of cancer","volume":"276","author":"Podojil","year":"2017","journal-title":"Immunol Rev"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02886-8","article-title":"TIGIT promotes CD8(+)T cells exhaustion and predicts poor prognosis of colorectal cancer","volume":"70","author":"Liang","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B168","doi-asserted-by":"publisher","first-page":"107986","DOI":"10.1016\/j.pharmthera.2021.107986","article-title":"Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach","volume":"231","author":"Chamseddine","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2016.6811","article-title":"Macrophage NOS2 in tumor leukocytes","volume":"26","author":"Brune","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132975","article-title":"Mitochondrial arginase-2 is a cell\u2212autonomous regulator of CD8+ T cell function and antitumor efficacy","volume":"4","author":"Mart\u00ed L\u00edndez","year":"2019","journal-title":"JCI Insight"},{"key":"B173","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/ph17070964","article-title":"Insights into immune exhaustion in chronic hepatitis B: A review of checkpoint receptor expression","volume":"17","author":"Costa","year":"2024","journal-title":"Pharm (Basel)"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.5009\/gnl220449","article-title":"Single-cell RNA sequencing shows T-cell exhaustion landscape in the peripheral blood of patients with hepatitis B virus-associated acute-on-chronic liver failure","volume":"18","author":"Yao","year":"2024","journal-title":"Gut Liver"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137553","article-title":"Hypoxia-inducible factors and innate immunity in liver cancer","volume":"130","author":"Yuen","year":"2020","journal-title":"J Clin Invest"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01379-9","article-title":"Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity","volume":"24","author":"Vignali","year":"2023","journal-title":"Nat Immunol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v151.5","article-title":"The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinoma","volume":"151","author":"Chen","year":"2022","journal-title":"Int J Cancer"},{"key":"B178","doi-asserted-by":"publisher","first-page":"e2300191","DOI":"10.1002\/adhm.202300191","article-title":"ROS scavenging nanozyme modulates immunosuppression for sensitized cancer immunotherapy","volume":"12","author":"Mo","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"B179","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","article-title":"The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo","volume":"42","author":"Blagih","year":"2015","journal-title":"Immunity"},{"key":"B180","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1158\/1538-7445.AM2023-2994","article-title":"Abstract 2994: Hypoxia blocks the presentation of tumor antigens to CD8+ T cells","volume":"83","author":"Smith","year":"2023","journal-title":"Cancer Res"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.706448","article-title":"DMF activates NRF2 to inhibit the pro-invasion ability of TAMs in breast cancer","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/jmalexu.2023.323222","article-title":"PD-1\/PD-L1 axis inhibitors as promising strategy for management of hepatocellular carcinoma: expectations, boundaries and pitfalls","volume":"44","author":"El Banna","year":"2023","journal-title":"J Med Res Institute"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c00279","article-title":"Virtual screening and biological evaluation of potential PD-1\/PD-L1 immune checkpoint inhibitors as anti-hepatocellular carcinoma agents","volume":"8","author":"Kamal","year":"2023","journal-title":"ACS Omega"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/biomedicines11041020","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: current strategies and biomarkers predicting response and\/or resistance","volume":"11","author":"Pelizzaro","year":"2023","journal-title":"Biomedicines"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1053\/j.gastro.2012.08.041","article-title":"Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV","volume":"143","author":"Fisicaro","year":"2012","journal-title":"Gastroenterology"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5396","article-title":"CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade","volume":"14","author":"Tang","year":"2016","journal-title":"Mol Med Rep"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.04.045","article-title":"Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"137","author":"Gehring","year":"2009","journal-title":"Gastroenterology"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648420","article-title":"Functional exhaustion of HBV-specific CD8 T cells impedes PD-L1 blockade efficacy in chronic HBV infection","volume":"12","author":"Ferrando-Martinez","year":"2021","journal-title":"Front Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"key":"B191","doi-asserted-by":"publisher","first-page":"e5275","DOI":"10.1097\/MD.0000000000005275","article-title":"Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B: A balance between immunity strength and liver injury extent","volume":"96","author":"Ye","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J Hepatol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/hep.32210","article-title":"Programmed death 1 expressing CD8(+) CXCR5(+) follicular T cells constitute effector rather than exhaustive phenotype in patients with chronic hepatitis B","volume":"75","author":"Khanam","year":"2022","journal-title":"Hepatology"},{"key":"B195","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bulcan.2018.01.018","article-title":"Blocking Tim-3 or\/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma","volume":"105","author":"Liu","year":"2018","journal-title":"Bull Cancer"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141852","article-title":"Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B","volume":"42","author":"Wu","year":"2012","journal-title":"Eur J Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PloS One"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30889","article-title":"Dual programmed death receptor-1 and vascular endothelial growth factor receptor-2 blockade promotes vascular normalization and enhances antitumor immune responses in hepatocellular carcinoma","volume":"71","author":"Shigeta","year":"2020","journal-title":"Hepatology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.02.036","article-title":"Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma","volume":"360","author":"Xiao","year":"2015","journal-title":"Cancer Lett"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1072-3","article-title":"Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization","volume":"39","author":"Xu","year":"2020","journal-title":"Oncogene"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"e2007603","DOI":"10.1002\/adma.202007603","article-title":"mRNA delivery of a bispecific single-domain antibody to polarize tumor-associated macrophages and synergize immunotherapy against liver Malignancies","volume":"33","author":"Wang","year":"2021","journal-title":"Adv Mater"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006493","article-title":"T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","article-title":"Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma","volume":"12","author":"Hung","year":"2021","journal-title":"Nat Commun"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328428","article-title":"Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences","volume":"72","author":"Chen","year":"2023","journal-title":"Gut"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0232","article-title":"MYC overexpression drives immune evasion in hepatocellular carcinoma that is reversible through restoration of proinflammatory macrophages","volume":"83","author":"Dhanasekaran","year":"2023","journal-title":"Cancer Res"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200389","article-title":"A novel trxR1 inhibitor regulates NK and CD8+ T cell infiltration and cytotoxicity, enhancing the efficacy of anti-PD-1 immunotherapy against hepatocarcinoma","volume":"210","author":"Su","year":"2023","journal-title":"J Immunol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0762-9","article-title":"B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function","volume":"48","author":"Cai","year":"2013","journal-title":"J Gastroenterol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1472430\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T07:49:10Z","timestamp":1728546550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1472430\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":209,"alternative-id":["10.3389\/fimmu.2024.1472430"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1472430","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"article-number":"1472430"}}